Favourites   Have ideas?  Sign in / Register

Positive:   Country: China ↓25.3   Radiotherapy ↓12.48   Cannabis ↓10.68 «See more»   Pain fight ↑6.92   Pharmaceutical  ↑17.33   Blood ↑33.9

Negative:   Bad infrastructure  ↓2.62


Cancer fight segment

ACET Adicet Bio, Inc. - Common Stock -10.6% -10.6% 0 + Medicine, Cancer fight

+ My List
ADAP Adaptimmune Therapeutics plc - American Depositary Shares 8.57% 8.57% 0 + Medicine, Cancer fight


Last highlighted: #ADAP SEC report: Adaptimmune Therapeutics PLC Statement of changes in beneficial ownership of securities
+ My List
AEMD Aethlon Medical, Inc. - Common Stock up -8.91% 8.91 + Health Devices, Medicine, Cancer fight

+ My List
AFMD Affimed N.V. - Common Stock -11.24% -11.24% 0 + Immunology, Cancer fight, Medicine

+ My List
AGEN Agenus Inc. - Common Stock 6.58% down 9.21% -2.63 + Cancer fight, Immunology, Medicine


Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities
+ My List
AIKI AIkido Pharma Inc. - Common Stock 0 + Cancer fight, Pharmaceutical , Medicine


Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058
+ My List
AKER Akers Biosciences Inc. - Common Stock 0.00% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
ALLO Allogene Therapeutics, Inc. - Common Stock 4.34% up -11.24% 15.58 + Cancer fight, Gene and cell, Medicine

+ My List
ALPN Alpine Immune Sciences, Inc. - Common Stock 12.35% 12.35% 0 + Medicine, Cancer fight

+ My List
ALRN Aileron Therapeutics, Inc. - Common Stock 0 + Cancer fight, Medicine, Biopharma

+ My List
ALXO ALX Oncology Holdings Inc. - Common Stock -7.3% -7.3% 0 + Medicine, Cancer fight

+ My List
ANAB AnaptysBio, Inc. - Common Stock 0.09% up -7.22% 7.31 + Immunology, Cancer fight, Medicine

+ My List
ANCN Anchiano Therapeutics Ltd. - American Depositary Shares 0.00% 0 + Cancer fight, Biopharma, Medicine, Country: Israel

+ My List
ANIX Anixa Biosciences, Inc. - Common Stock -11.94% -11.94% 0 + Cancer fight, Medicine, Immunology

+ My List
ANPC AnPac Bio-Medical Science Co., Ltd. - American Depositary Shares 0 + Cancer fight


Last highlighted: #ANPC SEC report: AnPac Bio-Medical Science Co., Ltd. [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
SEC Filing Form 20-F/A filed by AnPac Bio-Medical Science Co., Ltd. -- SEC File Number 211081601
+ My List
APOP Cellect Biotechnology Ltd. - American Depositary Shares 0.00% 0 + Country: Israel, Cancer fight, Medicine

+ My List
APRE Aprea Therapeutics, Inc. - Common Stock -24.17% -24.17% 0 + Medicine, Cancer fight


Last highlighted: Aprea Therapeutics Inc trading halted, news pending $APRE
+ My List
ARAV Aravive, Inc. - Common Stock 10.34% 10.34% 0 + Medicine, Cancer fight

+ My List
ATNX Athenex, Inc. - Common Stock 0 + Cancer fight, Biopharma, Covid (fighting)


Last highlighted: $ATNX 📜 SEC Form 10-Q filed by Athenex, Inc. https://t.co/1k3SCVGjG9 30 seconds delayed.
+ My List
AUTL Autolus Therapeutics plc - American Depositary Shares 13.33% 13.33% 0 + Country: Greate Britain, Gene and cell, Cancer fight, Medicine


Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6 https://t.co/Bswi1mwqgf
+ My List
AVCO Avalon GloboCare Corp. - Common Stock 0 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
AVEO AVEO Pharmaceuticals, Inc. - Common Stock 0.75% down 10% -9.25 + Medicine, Disease: Oncology, Cancer fight


Last highlighted: #AVEO SEC report: AVEO PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by AVEO PHARMACEUTICALS, INC. -- SEC File Number 211148137
+ My List
AWH Aspira Women's Health Inc. - Common Stock 0 + Cancer fight, Women Health, Medicine

+ My List
AYLA Ayala Pharmaceuticals, Inc. - Common Stock -9.8% -9.8% 0 + Medicine, Cancer fight

+ My List
BLRX BioLineRx Ltd. - American Depositary Shares -1.55% down 16.95% -18.5 + Medicine, Cancer fight

+ My List
BNGO Bionano Genomics, Inc. - Common Stock 6.71% down 14.18% -7.47 + Medicine, Cancer fight, Gene and cell


Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i
+ My List
BNGOW Bionano Genomics, Inc. - Warrant 0 + Cancer fight, Medicine, Gene and cell

+ My List
BNR Burning Rock Biotech Limited - American Depositary Shares -67.58% -67.58% 0 + Country: China, Cancer fight, Medicine

+ My List
BPTH Bio-Path Holdings, Inc. - Common Stock 1.77% up -7.96% 9.73 + Cancer fight, Medicine

+ My List
BYSI BeyondSpring, Inc. - Ordinary Shares 6.61% up -7.8% 14.41 + Cancer fight, Biopharma, Medicine, Immunology


Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR
+ My List
CALA Calithera Biosciences, Inc. - Common Stock 0 + Medicine, Cancer fight

+ My List
CBLI Cleveland BioLabs, Inc. - Common Stock 0.00% 0 + Cancer fight

+ My List
CCXI ChemoCentryx, Inc. - Common Stock -0.78% down 7.43% -8.21 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01
+ My List
CELC Celcuity Inc. - Common Stock 3.85% up -7.76% 11.61 + Cancer fight, Medicine


Last highlighted: #CELC SEC report: Celcuity Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Celcuity Inc. -- SEC File Number 211081754
+ My List
CGIX Cancer Genetics, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine

+ My List
CKPT Checkpoint Therapeutics, Inc. - Common Stock -5.56% down 14.73% -20.29 + Cancer fight, Medicine

+ My List
CLDX Celldex Therapeutics, Inc. - Common Stock -5.14% up -7.75% 2.61 + Cancer fight, Immunology, Medicine


Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052
+ My List
CLLS Cellectis S.A. - American Depositary Shares -8.15% -8.15% 0 + Biopharma, Medicine, Cancer fight

+ My List
CLRB Cellectar Biosciences, Inc. - Common Stock 0 + Medicine, Biopharma, Cancer fight


Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932
+ My List
CLSN Celsion Corporation - Common Stock -2.49% up -15.05% 12.56 + Cancer fight, Medicine

+ My List
CMPI Checkmate Pharmaceuticals, Inc. - Common Stock 327.57% up 326.75% 0.81999999999999 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205
+ My List
CNST Constellation Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Pharmaceutical

+ My List
CRDF Cardiff Oncology, Inc. - Common Stock -2.22% down 10.48% -12.7 + Cancer fight, Medicine


Last highlighted: #CRDF SEC report: Cardiff Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Cardiff Oncology, Inc. -- SEC File Number 211148042
+ My List
CRIS Curis, Inc. - Common Stock up -10% 10 + Cancer fight, Medicine

+ My List
CSTL Castle Biosciences, Inc. - Common stock 0.61% down 8.09% -7.48 + Cancer fight, Medicine

+ My List
CTMX CytomX Therapeutics, Inc. - Common Stock 0.56% down 7.41% -6.85 + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
+ My List
CUE Cue Biopharma, Inc. - Common Stock -1.98% up -14.15% 12.17 + Biopharma, Immunology, Cancer fight

+ My List
CYCCP Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock down 21.19% -21.19 + Cancer fight, Medicine, Biopharma


Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c
+ My List
DCTH Delcath Systems, Inc. - Common Stock 2.04% up -7.08% 9.12 + Cancer fight, Medicine, Disease: Liver


Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness
+ My List
DMTK DermTech, Inc. - Common Stock 1.7% down 11.01% -9.31 + Medicine, Cancer fight, Skin


Last highlighted: #DMTK SEC report: DermTech, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by DermTech, Inc. -- SEC File Number
+ My List
DTIL Precision BioSciences, Inc. - Common Stock -2.2% down 8.79% -10.99 + Cancer fight, Gene and cell, Food

+ My List
ENOB Enochian Biosciences, Inc. - Common Stock -7.32% -7.32% 0 + Disease: Infectious, Cancer fight, Immunology, Medicine

+ My List
EPIX ESSA Pharma Inc. - Common Stock 4.45% down 8.01% -3.56 + Pharmaceutical , Country: Canada, Cancer fight


Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253
+ My List
EPZM Epizyme, Inc. - Common Stock 0 + Cancer fight, Gene and cell

+ My List
FATE Fate Therapeutics, Inc. - Common Stock 0.57% up -8.83% 9.4 + Cancer fight, Immunology, Medicine

+ My List
FGEN FibroGen, Inc - Common Stock -4.02% down 12.85% -16.87 + Medicine, Cancer fight, Respiratory therapies / Pulmanory

+ My List
FLDM Fluidigm Corporation - Common Stock -7.02% -7.02% 0 + Life Sciences, Biology, Cancer fight, Biotechnology, RNA


Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270
+ My List
FPRX Five Prime Therapeutics, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine

+ My List
FUSN Fusion Pharmaceuticals Inc. - Common Shares -32.31% -32.31% 0 + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight

+ My List
GALT Galectin Therapeutics Inc. - Common Stock -2.88% up -7.35% 4.47 + Cancer fight, Disease: Liver, Skin, Medicine


Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679
+ My List
GLSI Greenwich LifeSciences, Inc. - Common stock -1.69% up -12.57% 10.88 + Medicine, Biopharma, Cancer fight, Immunology

+ My List
GNCA Genocea Biosciences, Inc. - Common Stock 0 + Cancer fight, Immunology, Medicine

+ My List
GNPX Genprex, Inc. - Common Stock -3.21% down 16.03% -19.24 + Cancer fight, Disease: Oncology, Medicine


Last highlighted: $GNPX [15s. delayed] filed form 10-Q on August 13, 16:34:15 https://t.co/cEVufMKwcd
+ My List
GOVX GeoVax Labs, Inc. - Common Stock up -22.64% 22.64 + Medicine, Cancer fight

+ My List
GRTS Gritstone Oncology, Inc. - Common Stock -1.73% up -8.08% 6.35 + Medicine, Immunology, Cancer fight

+ My List
GTH Genetron Holdings Limited - American Depositary Shares 4.93% down 10.16% -5.23 + Cancer fight, Medicine, Disease: Oncology, Country: China


Last highlighted: $GTH / Genetron Holdings Limited ADS files form 6-K https://t.co/3DehdripqL
+ My List
HCM Hutchison China MediTech Limited - American Depositary Shares -13.24% -13.24% 0 + Country: China, Medicine, Disease: Oncology, Cancer fight


Last highlighted: $HCM 📜 SEC Form 6-K filed by Hutchison China MediTech Limited https://t.co/3MQ4DYnXFz 15s delayed.
+ My List
HGEN Humanigen, Inc. - Common Stock -1.93% up -9.18% 7.25 + Biopharma, Immunology, Cancer fight, Medicine


Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187
+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock 2.63% down 10.49% -7.86 + Disease: Infectious, Immunology, Cancer fight, Medicine

+ My List
HTBX Heat Biologics, Inc. - Common Stock -7.41% -7.41% 0 + Medicine, Cancer fight

+ My List
ICAD icad inc. - Common Stock 3.8% up -9.42% 13.22 + Medicine, Devices, Cancer fight


Last highlighted: #ICAD SEC report: ICAD INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ICAD INC -- SEC File Number
+ My List
ILMN Illumina, Inc. - Common Stock -6.04% up -20.6% 14.56 + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health


Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268
+ My List
IMMP Immutep Limited - American Depositary Shares -9.47% -9.47% 0 + Cancer fight, Medicine

+ My List
IMNM Immunome, Inc. - Common Stock 2.9% down 12.24% -9.34 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMTX Immatics N.V. - Ordinary Shares 5.51% up -12.79% 18.3 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
INFI Infinity Pharmaceuticals, Inc. - Common Stock 0 + Medicine, Cancer fight


Last highlighted: #INFI SEC report: INFINITY PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by INFINITY PHARMACEUTICALS, INC. -- SEC File Number
+ My List
INMB INmune Bio Inc. - Common stock -7.19% -7.19% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock 1.15% down 8.46% -7.31 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock -8.59% -8.59% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
JNCE Jounce Therapeutics, Inc. - Common Stock 1.9% up -13.51% 15.41 + Immunology, Cancer fight, Medicine

+ My List
KPTI Karyopharm Therapeutics Inc. - Common Stock up -10.02% 10.02 + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine


Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number
+ My List
KRBP Kiromic BioPharma, Inc. - Common Stock 0 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals
+ My List
KTRA Kintara Therapeutics, Inc. - Common Stock 0 + Cancer fight, Medicine

+ My List
KURA Kura Oncology, Inc. - Common Stock -0.56% up -11.92% 11.36 + Cancer fight, Medicine


Last highlighted: #KURA SEC report: Kura Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kura Oncology, Inc. -- SEC File Number 211148278
+ My List
MACK Merrimack Pharmaceuticals, Inc. - Common Stock -2.24% down 7.72% -9.96 + Pharmaceutical , Cancer fight, Medicine

+ My List
MBRX Moleculin Biotech, Inc. - Common Stock -7.58% -7.58% 0 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities
+ My List
MGNX MacroGenics, Inc. - Common Stock 4.49% up -9.89% 14.38 + Medicine, Cancer fight

+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock 33.9% 33.9% 0 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MNPR Monopar Therapeutics Inc. - Common Stock -4.48% down 9.19% -13.67 + Cancer fight, Medicine, Biopharma


Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054
+ My List
MOR MorphoSys AG - American Depositary Shares -9.41% -9.41% 0 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
MREO Mereo BioPharma Group plc - American Depositary Shares 0 + Biopharma, Cancer fight, Country: Greate Britain


Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904
+ My List
MRKR Marker Therapeutics, Inc. - Common Stock 0 + Immunology, Medicine, Cancer fight


Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01
+ My List
MRSN Mersana Therapeutics, Inc. - Common Stock 3.27% up -12.04% 15.31 + Medicine, Cancer fight


Last highlighted: #MRSN SEC report: Mersana Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Mersana Therapeutics, Inc. -- SEC File Number
+ My List
MRUS Merus N.V. - Common Shares -2.31% up -9.87% 7.56 + Cancer fight, Medicine, Country: Netherlands


Last highlighted: #MRUS SEC report: Merus N.V. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Merus N.V. -- SEC File Number 211148220
+ My List
NCNA NuCana plc - American Depositary Shares 0 + Cancer fight, Disease: Oncology, Medicine

+ My List
NH NantHealth, Inc. - Common Stock -8.41% -8.41% 0 + Cancer fight, Medicine
- Bad infrastructure
+ My List
NK NantKwest, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Immunology
- Bad infrastructure
+ My List
NRIX Nurix Therapeutics, Inc. - Common stock -1.03% down 9.91% -10.94 + Biotechnology, Cancer fight, Immunology


Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020
+ My List
NVCR NovoCure Limited - Ordinary Shares -4.2% up -8.24% 4.04 + Cancer fight, Medicine

+ My List
ODT Odonate Therapeutics, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine


Last highlighted: #ODT SEC report: Odonate Therapeutics, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Odonate Therapeutics, Inc. -- SEC File Number 211148890
+ My List
ONCR Oncorus, Inc. - Common Stock 14.75% down 17.31% -2.56 + Cancer fight, Immunology, Biotechnology


Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316
+ My List
ONCS OncoSec Medical Incorporated - Common Stock 0 + Cancer fight, Disease: Oncology, Medicine, Immunology


Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number
+ My List
ONCY Oncolytics Biotech Inc. - Common Shares 6.67% up -10.08% 16.75 + Medicine, Cancer fight, Country: Canada, Immunology


Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8
+ My List
ORIC Oric Pharmaceuticals, Inc. - Common Stock -7.43% -7.43% 0 + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight


Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899
+ My List
PDSB PDS Biotechnology Corporation - Common Stock 3.28% down 11.36% -8.08 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PHIO Phio Pharmaceuticals Corp. - Common Stock up -9.09% 9.09 + Medicine, Cancer fight, Immunology


Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number
+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock -1.14% down 7.06% -8.2 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight


Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334
+ My List
PMVP PMV Pharmaceuticals, Inc. - Common Stock 0.37% down 8.23% -7.86 + Medicine, Cancer fight, Pharmaceutical


Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number
+ My List
POAI Predictive Oncology Inc. - Common Stock 0 + Cancer fight, Medicine, Artificial Intelligence


Last highlighted: #POAI SEC report: Predictive Oncology Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Predictive Oncology Inc. -- SEC File Number
+ My List
PRLD Prelude Therapeutics Incorporated - Common Stock up -9.42% 9.42 + Cancer fight, Medicine


Last highlighted: #PRLD SEC report: Prelude Therapeutics Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Prelude Therapeutics Inc -- SEC File Number
+ My List
PROG Progenity, Inc. - Common Stock -10% -10% 0 + Gene and cell, Medicine, Cancer fight, Women Health


Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number
+ My List
PSTV PLUS THERAPEUTICS, Inc. - Common Stock 0 + Cancer fight, Medicine, Radiotherapy


Last highlighted: #PSTV SEC report: PLUS THERAPEUTICS, INC. [Amend] Quarterly report [Sections 13 or 15(d)]
+ My List
QTRX Quanterix Corporation - Common Stock up -8.08% 8.08 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology


Last highlighted: #QTRX SEC report: Quanterix Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Quanterix Corp -- SEC File Number
+ My List
RAPT RAPT Therapeutics, Inc. - Common Stock -3.78% down 15.67% -19.45 + Cancer fight, Medicine


Last highlighted: #RAPT SEC report: RAPT Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by RAPT Therapeutics, Inc. -- SEC File Number
+ My List
REPL Replimune Group, Inc. - Common Stock -7.44% -7.44% 0 + Cancer fight


Last highlighted: #REPL SEC report: Replimune Group, Inc. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by Replimune Group, Inc. -- SEC File Number
+ My List
RIGL Rigel Pharmaceuticals, Inc. - Common Stock 6.83% down 7.14% -0.31 + Medicine, Cancer fight

+ My List
RUBY Rubius Therapeutics, Inc. - Common Stock -13.51% -13.51% 0 + Gene and cell, Cancer fight, Medicine

+ My List
RVMD Revolution Medicines, Inc. - Common Stock -28.74% -28.74% 0 + Cancer fight, Medicine, Biotechnology

+ My List
SESN Sesen Bio, Inc. - Common Stock 0 + Cancer fight, Medicine


Last highlighted: #SESN SEC report: Sesen Bio, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Sesen Bio, Inc. -- SEC File Number 211102791
+ My List
SLRX Salarius Pharmaceuticals, Inc. - Common Stock 0 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
+ My List
SLS SELLAS Life Sciences Group, Inc. - Common Stock 12.07% 12.07% 0 + Cancer fight, Medicine


Last highlighted: SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast https://www.sellaslifesciences.com/investors/news/News-Details/2020/SELLAS-Announces-Positive-Follow-up-Data-from-the-Randomized-Phase-2-VADIS-Trial-of-Nelipepimut-S-NPS-in-Women-with-Ductal-Carcinoma-In-Situ-of-the-Breast/default.aspx
+ My List
SNSS Sunesis Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Medicine, Biopharma, Cancer fight

+ My List
SONN Sonnet BioTherapeutics Holdings, Inc. - Common Stock 0 + Cancer fight, Biology, Medicine

+ My List
SRNE Sorrento Therapeutics, Inc. - Common Stock 6.92% down 7.44% -0.52 + Pain fight, Cancer fight, Medicine

+ My List
STRO Sutro Biopharma, Inc. - Common Stock 4.18% up -8.73% 12.91 + Cancer fight, Medicine

+ My List
SURF Surface Oncology, Inc. - Common Stock 1.46% down 8.33% -6.87 + Cancer fight, Immunology, Medicine


Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938
+ My List
SYRS Syros Pharmaceuticals, Inc. - common stock up -16.83% 16.83 + Gene and cell, Medicine, Cancer fight

+ My List
TARA Protara Therapeutics, Inc. - Common Stock 4.49% down 7.96% -3.47 + Cancer fight, Medicine

+ My List
TCON TRACON Pharmaceuticals, Inc. - Common Stock -1.54% down 13.53% -15.07 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

+ My List
TCRR TCR2 Therapeutics Inc. - Common Stock -2.07% down 8.76% -10.83 + Cancer fight, Medicine

+ My List
THTX Theratechnologies Inc. - Common Shares 4.82% down 7.26% -2.44 + Cancer fight, Biopharma, Medicine

+ My List
TRIL Trillium Therapeutics Inc. - Common Shares 0.00% 0 + Country: Canada, Cancer fight, Disease: Oncology, Immunology


Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number
+ My List
TTOO T2 Biosystems, Inc. - Common Stock 0 + Medicine, Cancer fight


Last highlighted: #TTOO SEC report: T2 Biosystems, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by T2 Biosystems, Inc. -- SEC File Number
+ My List
TYME Tyme Technologies, Inc. - Common Stock 0 + Cancer fight, Medicine


Last highlighted: #TYME SEC report: TYME TECHNOLOGIES, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by TYME TECHNOLOGIES, INC. -- SEC File Number
+ My List
VBLT Vascular Biogenics Ltd. - Ordinary Shares 9.22% 9.22% 0 + Country: Israel, Biopharma, Cancer fight, Medicine

+ My List
VERU Veru Inc. - Common Stock -10.11% -10.11% 0 + Cancer fight, Medicine


Last highlighted: Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript
+ My List
VRAY ViewRay, Inc. - Common Stock -5.14% down 8.55% -13.69 + Cancer fight, Radiotherapy, Medicine


Last highlighted: #VRAY SEC report: ViewRay, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by ViewRay, Inc. -- SEC File Number 211148242
+ My List
VSTM Verastem, Inc. - Common Stock 9.26% 9.26% 0 + Biopharma, Cancer fight, Medicine


Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620
+ My List
XBIO Xenetic Biosciences, Inc. - Common Stock 0 + Biopharma, Cancer fight, Disease: Oncology, Medicine

+ My List
XFOR X4 Pharmaceuticals, Inc. - Common Stock -8.73% -8.73% 0 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073
+ My List
YMAB Y-mAbs Therapeutics, Inc. - Common Stock -3.74% down 13.19% -16.93 + Biopharma, Cancer fight, Medicine


Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421
+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock -8.18% -8.18% 0 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
ZNTL Zentalis Pharmaceuticals, Inc. - common stock 4.73% down 18.04% -13.31 + Cancer fight, Biology, Pharmaceutical , Medicine


Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number
+ My List
BCTX BriaCell Therapeutics Corp. - Common Shares 6.3% up -8.37% 14.67 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540
+ My List
BOLT Bolt Biotherapeutics, Inc. - Common Stock -9.36% -9.36% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
ENVB Enveric Biosciences, Inc. - Common Stock -10.68% -10.68% 0 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155
+ My List
EVAX Evaxion Biotech A/S - American Depositary Share 6.15% down 7.45% -1.3 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
FSTX F-star Therapeutics, Inc. - Common Stock -7.23% -7.23% 0 + Immunology, Medicine, Cancer fight, Disease: Oncology


Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number
+ My List
GTBP GT Biopharma, Inc. - Common Stock 15.42% 15.42% 0 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
LIXT Lixte Biotechnology Holdings, Inc. - Common Stock up -19.83% 19.83 + Biotechnology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663
+ My List
OCX OncoCyte Corporation - Common Stock -7.83% down -3.48% -4.35 + Cancer fight, Diagnosing, Medicine


Last highlighted: #OCX SEC report: OncoCyte Corp Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OncoCyte Corp -- SEC File Number 211160996
+ My List
PPBT Purple Biotech Ltd. - American Depositary Shares 7.93% up 6.55% 1.38 + Country: Israel, Cancer fight, Disease: Oncology

+ My List
PRTG Portage Biotech Inc. - Common Stock 8.5% 8.5% 0 + Country: Canada, Immunology, Cancer fight, Disease: Oncology

+ My List
SBTX Silverback Therapeutics, Inc. - Common Stock 7.07% 7.07% 0 + Cancer fight, Disease: Oncology, Disease: Infectious, Medicine

+ My List
SCPS Scopus BioPharma Inc. - Common Stock 0 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List
VOR Vor Biopharma Inc. - Common Stock -4.3% up -7.25% 2.95 + Biopharma, Medicine, Cancer fight, Disease: Oncology

+ My List
IKNA Ikena Oncology, Inc. - Common Stock -14.29% -14.29% 0 + Cancer fight, Disease: Oncology, Medicine

+ My List
LVTX LAVA Therapeutics N.V. - Ordinary Shares -7.1% -7.1% 0 + T cell-based, Cancer fight, Medicine, Disease: Oncology

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.